| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.25 | 2e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.24 | 8e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |